7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment

      review-article
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Our knowledge and understanding of the tumor microenvironment (TME) have been recently expanded with the recognition of the important role of innate lymphoid cells (ILC). Three different groups of ILC have been described based on their ability to produce cytokines that mediate the interactions between innate and adaptive immune cells in a variety of immune responses in infection, allergy, and autoimmunity. However, recent evidence from experimental models and clinical studies has demonstrated that ILC contribute to the mechanisms that generate suppressive or tolerant environments that allow tumor regression or progression. Defining the complex network of interactions and crosstalk of ILC with other immune cells and understanding the specific contributions of each type of ILC leading to tumor development will allow the manipulation of their function and will be important to develop new interventions and therapeutic strategies.

          Related collections

          Most cited references70

          • Record: found
          • Abstract: found
          • Article: not found

          Immunological hallmarks of stromal cells in the tumour microenvironment.

          A dynamic and mutualistic interaction between tumour cells and the surrounding stroma promotes the initiation, progression, metastasis and chemoresistance of solid tumours. Far less understood is the relationship between the stroma and tumour-infiltrating leukocytes; however, emerging evidence suggests that the stromal compartment can shape antitumour immunity and responsiveness to immunotherapy. Thus, there is growing interest in elucidating the immunomodulatory roles of the stroma that evolve within the tumour microenvironment. In this Review, we discuss the evidence that stromal determinants interact with leukocytes and influence antitumour immunity, with emphasis on the immunological attributes of stromal cells that may foster their protumorigenic function.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo.

              We have characterized a cytokine produced by Th2 cells, designated as IL-25. Infusion of mice with IL-25 induced IL-4, IL-5, and IL-13 gene expression. The induction of these cytokines resulted in Th2-like responses marked by increased serum IgE, IgG(1), and IgA levels, blood eosinophilia, and pathological changes in the lungs and digestive tract that included eosinophilic infiltrates, increased mucus production, and epithelial cell hyperplasia/hypertrophy. In addition, our studies show that IL-25 induces Th2-type cytokine production by accessory cells that are MHC class II(high), CD11c(dull), and lineage(-). These results suggest that IL-25, derived from Th2 T cells, is capable of amplifying allergic type inflammatory responses by its actions on other cell types.
                Bookmark

                Author and article information

                Journal
                J Immunol Res
                J Immunol Res
                JIR
                Journal of Immunology Research
                Hindawi Publishing Corporation
                2314-8861
                2314-7156
                2016
                12 October 2016
                : 2016
                : 7803091
                Affiliations
                1Breast Cancer Now Research Unit, Division of Cancer Studies, Guy's Hospital, King's College London School of Medicine, London SE1 9RT, UK
                2Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, King's College London, Guy's Medical School Campus, London SE1 1ULK, UK
                3Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London SW3 6JB, UK
                4UCL Cancer Institute, Paul O'Gorman Building, University College London, London WC1E 6DD, UK
                Author notes

                Academic Editor: Menaka C. Thounaojam

                Author information
                http://orcid.org/0000-0002-0881-8822
                Article
                10.1155/2016/7803091
                5110869
                27882334
                b65f6f0d-c0c3-405d-ac09-0cb58e9b8d44
                Copyright © 2016 Fabian Flores-Borja et al.

                This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 16 June 2016
                : 20 August 2016
                : 30 August 2016
                Funding
                Funded by: KCL Breast Cancer Now Unit funding
                Funded by: Dimbleby Cancer Care to King's College London
                Funded by: KCL-UCL Comprehensive Cancer Imaging Centre
                Categories
                Review Article

                Comments

                Comment on this article